Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation
2022 · BMC Cancer · 33 citations
https://doi.org/10.1186/s12885-022-09171-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
631
Citations
10
h-index
11
i10-index
Nandi J. Reddy is an academic researcher from Nagpur Institute of Technology. The author has contributed to research in topics: Cancer therapeutics and mechanisms & Pancreatic and Hepatic Oncology Research & Gastric Cancer Management and Outcomes. The author has an h-index of 10, co-authored 35 publications.
Click to start Chat